Minervax ApS

Minervax ApS develops biotechnology solutions focused on immunization and vaccine research. The Company conducts clinical trials for maternal and older adult immunization and researches protein-only vaccines targeting Group B Streptococcus. Minervax ApS serves pregnant women and older adults at risk of GBS infection in the United Kingdom, South Africa, and Denmark.